- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x KJJ: (2~{S})-2-[4-(8-fluoranyl-5-methyl-3,4-dihydro-2~{H}-chromen-6-yl)-2-methyl-6-[[(1~{S},2~{R})-2-phenylcyclopropyl]methyl]-7,8-dihydro-5~{H}-1,6-naphthyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid(Non-covalent)
KJJ.5: 16 residues within 4Å:- Chain A: Q.66, A.69, T.95, T.96, K.98, A.99, A.100, W.102, W.103
- Chain B: Q.139, A.140, E.141, H.142, T.145, M.149
- Ligands: EDO.4
11 PLIP interactions:5 interactions with chain B, 6 interactions with chain A- Hydrophobic interactions: B:T.145, A:Q.66, A:T.96, A:A.99, A:W.102, A:W.103
- Hydrogen bonds: B:E.141, B:H.142, B:T.145
- Salt bridges: B:H.142
- Water bridges: A:Q.66
KJJ.12: 16 residues within 4Å:- Chain A: Q.139, A.140, E.141, H.142, T.145, M.149
- Chain B: Q.66, A.69, T.95, T.96, K.98, A.99, A.100, W.102, W.103
- Ligands: EDO.11
12 PLIP interactions:6 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:T.145, B:Q.66, B:T.96, B:A.99, B:W.102, B:W.103
- Hydrogen bonds: A:E.141, A:H.142, A:T.145, A:T.145
- Salt bridges: A:H.142
- Water bridges: B:Q.66
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 5 residues within 4Å:- Chain A: K.42, R.137, E.141, H.142, L.143
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:E.141, A:L.143
- Water bridges: A:K.42, A:K.144
- Salt bridges: A:K.42, A:H.142
SO4.7: 2 residues within 4Å:- Chain A: K.82, K.107
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:K.82, A:K.107
SO4.13: 5 residues within 4Å:- Chain B: K.42, R.137, E.141, H.142, L.143
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:E.141, B:L.143
- Water bridges: B:K.42, B:K.144
- Salt bridges: B:K.42, B:H.142
SO4.14: 2 residues within 4Å:- Chain B: K.82, K.107
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:K.82, B:K.107
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Peese, K.M. et al., 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors. J. Med. Chem. (2019)
- Release Date
- 2019-01-16
- Peptides
- Integrase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x KJJ: (2~{S})-2-[4-(8-fluoranyl-5-methyl-3,4-dihydro-2~{H}-chromen-6-yl)-2-methyl-6-[[(1~{S},2~{R})-2-phenylcyclopropyl]methyl]-7,8-dihydro-5~{H}-1,6-naphthyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Peese, K.M. et al., 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors. J. Med. Chem. (2019)
- Release Date
- 2019-01-16
- Peptides
- Integrase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A